MTD · Q3 2025 Earnings

Cautious

Mettler Toledo

Reported November 6, 2025

30-second summary

Mettler beat its own Q3 guide cleanly — adjusted EPS of $11.15 vs. $10.55–$10.75 guide, with local-currency sales +6% vs. +3–4% guide — and raised FY2025 adjusted EPS to $42.05–$42.25 from $41.70–$42.20. But management explicitly attributed core industrial strength (+10% organic) to easy comps and customer timing, guided Q4 core industrial down to low single digit, and disclosed a Q4 tariff headwind of 7% vs. the 5% embedded in the Q3 guide. The first 2026 frame — +4% LC growth, adjusted EPS $45.35–$46.00 (+8% to +9%) — assumes no market improvement and defers full tariff offset to next year.

Headline numbers

EPS

Q3 FY2025

$11.15

Revenue

Q3 FY2025

$1.03B

+8.0% YoY

Gross margin

Q3 FY2025

59.2%

Operating margin

Q3 FY2025

30.1%

Key financials

Q3 FY2025

Metric	Q3 FY2025	YoY	Q2 FY2025	QoQ
Revenue	$1.03B	+8.0%	$0.98B	+4.8%
EPS	$11.15	—	$10.09	+10.5%
Gross margin	59.2%	—	59.0%	+20bps
Operating margin	30.1%	—	28.8%	+130bps

Guidance

Company raised FY2025 EPS guidance post-strong Q3 beat, with Q3 actual EPS of $11.15 and 6% local-currency sales growth each exceeding guidance; forward Q4 and FY2026 outlooks introduced with escalated tariff headwinds noted.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

Metric	Period	Prior guide	Actual	Δ	Result
Adjusted EPS	Q3 FY2025	$10.55 to $10.75	$11.15	+$0.40 to $0.60 above guide	Beat
Local Currency Sales Growth	Q3 FY2025	3% to 4%	6%	+2 to 3 percentage points above guide	Beat
Adjusted EPS Growth Rate	Q3 FY2025	3% to 5%	9%	+4 to 6 percentage points above guide	Beat

New guidance

Metric	Period	Guide	YoY
Adjusted EPS	Q4 FY2025	$12.68 to $12.88	2% to 4%
Local Currency Sales Growth	Q4 FY2025	approximately 3%	—
Tariff Headwind to EPS Growth	Q4 FY2025	approximately 7% gross headwind	—
Tariff Headwind to EPS	FY2025	approximately 5% gross headwind	—
Shipping Delay Headwind to EPS	FY2025	approximately 4%	—

Changes to prior guidance

Metric	Period	Prior guide	New guide	Δ	Result
Adjusted EPS	FY2025	$41.70 to $42.20	$42.05 to $42.25	+$0.35 to $0.55 at midpoint vs prior range	Raised
Local Currency Sales Growth	FY2025	1% to 2%	approximately 2%	raised to midpoint of prior range; slightly higher midpoint implies ~+0.5pp confidence	Raised
Adjusted EPS Growth Rate	FY2025	1% to 3%	approximately 2% to 3%	+1pp at low end vs prior range	Raised

Other KPIs

Q3 FY2025

Segment	Q3 FY2025
Adjusted Operating Profit	$309.9 million
Local Currency Sales Growth	6%
Adjusted EPS Growth	9%

Management tone

Narrative arc: Tariff offset within year → Swiss tariff shock, offset pushed to 2026 → Beat the lowered bar, but Q4 tariff drag re-accelerates and 2026 growth pegged at structurally lower run-rate.

Last quarter management deferred tariff mitigation to 2026 with a confident "we will fully offset" framing. This quarter the language shifted to future-tense expectation: "we continue to expect to fully offset incremental tariffs cost in 2026." Combined with the Q4 tariff headwind stepping up from 5% (Q3 guide) to 7% (Q4 guide), the offset narrative is now aspirational rather than demonstrated — and the 2pp Q4 escalation says trade-policy pressure is intensifying, not abating, as management exits the year.

Two quarters ago, core industrial strength was framed as portfolio execution and share gains; last quarter it was carried by product inspection's mid-range portfolio. This quarter, with +10% organic core industrial as the headline beat driver, management immediately disqualified it: "growth in our core industrial business was very strong this quarter, especially in the Americas, although it benefited from easy multi-year growth comparisons and favorable timing of customer activity. Global market conditions for industrials are soft." Guiding Q4 core industrial down to low single digit confirms the disqualification is operational, not rhetorical.

The macro posture hardened from "we are not assuming market conditions improve" (Q2) to embedding that assumption into 2026: "Our forecast does not assume a significant improvement in market conditions over the coming year." Patrick echoed it: 2026 +4% growth "assumes market conditions do not significantly improve from current levels." This is the second consecutive quarter where management has explicitly removed cyclical recovery from the base case — a meaningful break from MTD's typical forward optimism.

The geographic story rebalanced. China returned to growth (+2% LC, first time in two years), but management de-emphasized it: "emerging markets outside of China have continued to grow and, in total, are now larger than China." China is no longer the swing variable for the bull thesis; emerging-markets-ex-China and onshoring-driven Americas demand have taken its place.

Margin commentary turned defensive. YTD adjusted operating profit is down 2% with margin compressed 130bps despite productivity initiatives; Q4 operating margin is guided to decline ~200bps YoY. The 2026 bridge management offered in Q&A — ~60bps currency-neutral expansion, ~20–30bps reported — confirms structural headwinds (tariffs, Swiss FX) are absorbing operational improvements rather than allowing them to flow through.

Recurring themes management leaned on this quarter:

Tariff costs as persistent structural headwind (140 bps Q3, 7% EPS headwind Q4 guidance)Industrial segment strength from easy comps and timing, not sustainable demandMarket conditions assumed flat-to-challenging with no material recovery baked into guidanceDigital transformation (Spinnaker 6, Blue Ocean ERP) as competitive moat amid uncertaintyGeographic rebalancing: Emerging markets ex-China now larger than ChinaService and automation opportunities as offset to core product softness

Risks management surfaced:

Trade disputes dynamic with potential for new tariffs not factored into guidanceGeopolitical tensions and US governmental policy uncertaintyChina capacity reduction efforts creating headwinds despite modest recoverySoft global market conditions in industrials with low single-digit growth expected Q4Currency volatility (noted as 2.5% Q4 benefit and 1% 2026 benefit)

Q&A highlights

Vijay Kumar · Evercore ISI

Why does 4% 2026 guidance represent a step-down from 4.5% back-half 2025 average, and how should we think about price versus volume dynamics given tariff headwinds abating?

Management attributes the lower guidance to persistent market uncertainty around trade politics and tariffs, leading to customer uncertainty. They highlighted that 2H25 benefits from ~3.5% pricing (vs ~2.5% assumed for 2026), and organic volume growth will be modest. They note tariffs create a ~6% gross headwind in 2026 that they expect to offset via cost actions and pricing. Currency headwinds (Swiss franc strength) will partially offset tariff relief on operating margins.

4% organic growth guidance for 20263.5% pricing benefit in Q3, similar expected in Q42.5% price realization assumed for full year 2026~6% gross tariff headwind in 2026 expected to be fully offset

Doug Schenkel · Wolfe Research

How much of Lab's outperformance was driven by process analytics vs. traditional lab equipment? Are CDMOs building brownfield U.S. plants driving bioprocessing sensor demand? Why was Q3 industrial growth (9% organic) so strong and will it normalize in Q4?

Process analytics (particularly bioprocessing sensors) was a key driver of Lab strength, with additional tailwinds from power/data center investments. On industrial, management attributed Q3 outperformance to favorable timing of activity across regions, including transportation/logistics automation (dynamic dimensioning) and broader automation/digitalization demand. They acknowledged easier Q3 comps and expect Q4 core industrial to decelerate to low single-digit growth, with timing dynamics skewing activity toward Q3.

Lab growth highlighted by bioprocessing sensors and process analyticsIndustrial (core) Q3 organic growth 10%, Q4 guidance low single-digitProduct inspection Q3 up 7%, Q4 guidance high single-digitQ3 easier comp; Q4 expected to be more difficult

Luke Sargop · Barclays

Can you provide 2026 guidance breakdown by segment, particularly industrial/PID/core industrial? How are consumer-facing segments like PID performing against weakening consumer backdrop?

Management guided lab business to low-to-mid single-digit growth with process analytics expected to outperform; bioprocessing momentum expected to continue. Core industrial and product inspection both low-to-mid single-digit. Retail expected flat. Geographically: Americas mid single-digit, Europe low single-digit, China low single-digit. On PID, despite challenging end-market conditions (70% food manufacturing exposure), management highlighted innovation in portfolio targeting middle market, strong execution, and positive pipeline momentum.

Lab: low-to-mid single-digit growthProcess analytics expected to outperform lab averageCore industrial: low-to-mid single-digitProduct inspection: low-to-mid single-digit with acquisition benefit

Patrick Donnelly · CD

What trends are you seeing in core industrial? What is your visibility on forward momentum given customer conversations?

Management stated core industrial is performing well despite challenging macro (PMI still below 50), driven by demand for automation, digitalization, and innovation. They highlighted strength in China's return to growth for first time in two years. Management expects soft conditions to persist but sees strong positioning for onshoring/reshoring activities requiring digital and automation solutions. Execution and competitive portfolio positioning were emphasized.

Core industrial showing strong execution in challenging market (PMI below 50)China core industrial returned to growth for first time in 2 yearsPortfolio strength in automation and digitalization capabilitiesPositioned for onshoring/reshoring demand

Michael Riskin · Bank of America

Can you detail Q3 vs Q4 segment results and any pull-forward timing or government shutdown impacts? What are the drivers of the step-down from Q3 to Q4?

Management provided detailed Q3-to-Q4 guidance by segment: Lab down from +4% to low single-digit (budget caution, seasonality, government policy uncertainty); Core industrial down from +11% (10% organic) to low single-digit (timing skew to Q3, harder comps); Product inspection +7% to high single-digit; Retail +5% to ~10%. Geographically: Americas +10% (8% organic) to mid single-digit; Europe +6% constant currency to flattish; China +2% to low single-digit. Management attributed slowdown to timing dynamics, harder comps, and cautious customer sentiment.

Lab Q3 +4%, Q4 guidance low single-digitCore industrial Q3 +11% (10% organic), Q4 low single-digitProduct inspection Q3 +7%, Q4 high single-digitRetail Q3 +5%, Q4 ~10%

Answers to last quarter's watch list

Q3 adjusted EPS vs. $10.55–$10.75 guide. Hit $11.15 — clean beat of $0.40–$0.60 driven by +6% LC sales vs. +3–4% guide and 9% adjusted EPS growth vs. 3–5% guide. FY2025 guide raised to $42.05–$42.25 from $41.70–$42.20.

Resolved positively

Product inspection vs. upgraded mid-to-high single digit FY guide. Q3 grew 7% with Q4 guided to high single digit; the segment remains an operational offset, though no longer the standout it was last quarter.

Resolved positively

Swiss tariff rate trajectory. No de-escalation. Q4 gross tariff headwind to adjusted EPS growth stepped up to ~7% from the ~5% embedded in last quarter's Q3 guide; FY2025 carve-out now explicitly ~5% tariff plus ~4% shipping delays.

Resolved negatively

China local-currency growth. China +2% LC in Q3 (first growth in two years) vs. Q2's -2%; Q4 guided low single digit. Modest recovery, but management explicitly repositioned emerging markets ex-China as now larger and more important.

Resolved positively

Concrete 2026 mitigation disclosure. Management committed to fully offset incremental tariff costs in 2026 via cost actions and pricing (~2.5% assumed), with ~6% gross 2026 tariff headwind framed and ~60bps currency-neutral operating margin expansion as the bridge. Quantification improved versus last quarter, though specifics on the cost-action component remain qualitative.

Continue monitoring

Replacement-cycle conversion. Not called out as the driver of Q3 strength; management instead attributed +10% core industrial growth to easy comps and customer timing rather than replacement demand. The thesis remains deferred.

Continue monitoring

What to watch into next quarter

Whether Q4 adjusted EPS lands in the $12.68–$12.88 guide despite the 7% gross tariff headwind. A miss confirms the tariff step-up is outrunning mitigation and puts the 2026 8–9% EPS growth frame at risk.

Q4 core industrial growth vs. the low-single-digit guide. This directly tests whether Q3's +10% organic was timing or a new run-rate — a print closer to mid-single digit would meaningfully de-risk the 2026 +4% LC growth setup.

Quantified 2026 tariff offset bridge. Management has committed to ~6% gross headwind being fully offset; investors should expect a quantified split between pricing (~2.5%), cost actions, and supply-chain re-routing on the next print rather than further qualitative reassurance.

Q4 adjusted operating margin vs. the guided ~200bps YoY decline. A worse outcome signals that pricing is not keeping pace with tariff and Swiss FX drag exiting the year, undermining the 2026 +60bps currency-neutral expansion math.

Process analytics / bioprocessing growth rate. Management positioned this as the 2026 outperformer within Lab; any deceleration removes the most credible secular growth story in the portfolio.

Tariff rate trajectory between now and the Q4 print. A further escalation would compound the 2pp Q4 step-up already announced; any de-escalation creates upside to the 2026 8–9% EPS growth frame.

Sources

Mettler-Toledo Q3 2025 press release (SEC 8-K exhibit 99.1): https://www.sec.gov/Archives/edgar/data/1037646/000103764625000056/ex-991mtd8xkq32025.htm
Mettler-Toledo Q3 2025 earnings call commentary (management prepared remarks and analyst Q&A).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.